OMX Copenhagen 25 GI (OMXC25GI.CO)

Close: 1 700.93 (-6.40), Dec 2, 2020
Weak Positive

Low risk

Automatic technical analysis. Medium term, Dec 2, 2020

Investors have paid higher prices over time to buy OMX Copenhagen 25 GI and the index is in a rising trend channel in the medium long term. Rising trends indicate that the market experiences positive development and that buy interest among investors is increasing. The price has risen strongly since the positive signal from rectangle formation at the break through the resistance at 1615. The objective at 1674 is now met, but the formation still gives a signal in the same direction. The index is testing the resistance at points 1720. This could give a negative reaction, but an upward breakthrough of points 1720 means a positive signal. The index is overall assessed as technically slightly positive for the medium long term.

Recommendation one to six months: Weak Positive (Score: 36)

Period  
Vol.bal. Volatility Liquidity +/- %
1 day-0.92%0.00-0.37%
5 days0.003.01%0.00+0.82%
22 days0.008.41%0.00+5.29%
66 days0.0018.76%0.00+7.56%

More analyses of OMX Copenhagen 25 GI

chart OMX Copenhagen 25 GI (OMXC25GI) Candlesticks 22 Days
Candlesticks
chart OMX Copenhagen 25 GI (OMXC25GI) Short term
Short term: Weak Positive
chart OMX Copenhagen 25 GI (OMXC25GI) Medium term
Medium term: Weak Positive
chart OMX Copenhagen 25 GI (OMXC25GI) Long term
Long term: Positive
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK